281 related articles for article (PubMed ID: 364993)
1. Gastrointestinal absorption II. Formulation factors affecting drug bioavailability.
Blanchard J
Am J Pharm Sci Support Public Health; 1978; 150(5):132-51. PubMed ID: 364993
[No Abstract] [Full Text] [Related]
2. Bioavailability: some pharmaceutical factors.
Fowle AS
Trans Med Soc Lond; 1975; 91():23-32. PubMed ID: 1236035
[No Abstract] [Full Text] [Related]
3. Drug formulation and biologic availability.
Poole JW
Semin Drug Treat; 1971 Sep; 1(2):148-76. PubMed ID: 5153883
[No Abstract] [Full Text] [Related]
4. [Drugs and the organism. II. Bioavailability].
Pflegel P; Pfeifer S
Pharmazie; 1980; 34(5-6):337-59. PubMed ID: 6893363
[No Abstract] [Full Text] [Related]
5. The utility of cyclodextrins for enhancing oral bioavailability.
Carrier RL; Miller LA; Ahmed I
J Control Release; 2007 Nov; 123(2):78-99. PubMed ID: 17888540
[TBL] [Abstract][Full Text] [Related]
6. Influence of formulation factors on the availability of drugs from topical preparations.
Asche H; Botta L; Rettig H; Weirich EG
Pharm Acta Helv; 1985; 60(8):232-7. PubMed ID: 4070318
[No Abstract] [Full Text] [Related]
7. Approaches for the development of solid and semi-solid lipid-based formulations.
Jannin V; Musakhanian J; Marchaud D
Adv Drug Deliv Rev; 2008 Mar; 60(6):734-46. PubMed ID: 18045728
[TBL] [Abstract][Full Text] [Related]
8. Lipid excipients and delivery systems for pharmaceutical development: a regulatory perspective.
Chen ML
Adv Drug Deliv Rev; 2008 Mar; 60(6):768-77. PubMed ID: 18077051
[TBL] [Abstract][Full Text] [Related]
9. [Effect of formulation of enterosoluable preparations on the physiologic availability of the active principle. 1: Effect on the rate of liberation of acetylsalicylic acid from enteric tablets on absorption characteristics in vivo].
Delporte JP; Jaminet F
J Pharm Belg; 1975; 30(2):99-113. PubMed ID: 1206458
[No Abstract] [Full Text] [Related]
10. Effect of gastric emptying on bioavailability of solid dosage forms.
Tamassia V; Simioni L; Tommasini R
Boll Chim Farm; 1978 Mar; 117(3):135-44. PubMed ID: 743364
[No Abstract] [Full Text] [Related]
11. Drug dissolution: significance of physicochemical properties and physiological conditions.
Jambhekar SS; Breen PJ
Drug Discov Today; 2013 Dec; 18(23-24):1173-84. PubMed ID: 24042023
[TBL] [Abstract][Full Text] [Related]
12. Sustained delivery of intact drug to the colon: mesalamine formulation and temporal gastrointestinal transit analysis.
Chuong MC; Christensen JM; Ayres JW
Pharm Dev Technol; 2009; 14(1):116-25. PubMed ID: 18821272
[TBL] [Abstract][Full Text] [Related]
13. Confounding factors for sex differences in pharmacokinetics and pharmacodynamics: focus on dosing regimen, dosage form, and formulation.
Chen ML
Clin Pharmacol Ther; 2005 Oct; 78(4):322-9. PubMed ID: 16198651
[No Abstract] [Full Text] [Related]
14. [Galenical possibilities and problems in protraction of drug effects (author's transl)].
Müller F
Arzneimittelforschung; 1976; 26(1A):115-21. PubMed ID: 7277
[TBL] [Abstract][Full Text] [Related]
15. Vitamins in pharmaceutical formulations.
DeRitter E
J Pharm Sci; 1982 Oct; 71(10):1073-96. PubMed ID: 6754906
[No Abstract] [Full Text] [Related]
16. Predictive models for oral drug absorption: from in silico methods to integrated dynamical models.
Dokoumetzidis A; Kalantzi L; Fotaki N
Expert Opin Drug Metab Toxicol; 2007 Aug; 3(4):491-505. PubMed ID: 17696801
[TBL] [Abstract][Full Text] [Related]
17. Estimating drug solubility in the gastrointestinal tract.
Dressman JB; Vertzoni M; Goumas K; Reppas C
Adv Drug Deliv Rev; 2007 Jul; 59(7):591-602. PubMed ID: 17599644
[TBL] [Abstract][Full Text] [Related]
18. Pharmaceutical applications of AC biosusceptometry.
Corá LA; Américo MF; Romeiro FG; Oliveira RB; Miranda JR
Eur J Pharm Biopharm; 2010 Jan; 74(1):67-77. PubMed ID: 19482083
[TBL] [Abstract][Full Text] [Related]
19. Effect of formulation on dissolution and bioavailability of phenytoin tablets.
Chakrabarti S; Belpaire F; Moerman E
Pharmazie; 1980; 35(10):627-9. PubMed ID: 7454745
[TBL] [Abstract][Full Text] [Related]
20. Rationalizing the selection of oral lipid based drug delivery systems by an in vitro dynamic lipolysis model for improved oral bioavailability of poorly water soluble drugs.
Dahan A; Hoffman A
J Control Release; 2008 Jul; 129(1):1-10. PubMed ID: 18499294
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
